Davide Firinu

InstitutionUniversity of Cagliari
AddressMonserrato
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in November 2020
    All Publications
    Bar chart showing 32 publications over 11 distinct years, with a maximum of 5 publications in 2018 and 2020 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Littera R, Chessa L, Deidda S, Angioni G, Campagna M, Lai S, Melis M, Cipri S, Firinu D, Santus S, Lai A, Porcella R, Rassu S, Meloni F, Schirru D, Cordeddu W, Kowalik MA, Ragatzu P, Vacca M, Cannas F, Alba F, Carta MG, Del Giacco S, Restivo A, Deidda S, Palimodde A, Congera P, Perra R, Orrù G, Pes F, Loi M, Murru C, Urru E, Onali S, Coghe F, Giglio S, Perra A. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. PLoS One. 2021; 16(8):e0255608. PMID: 34352002.
      Citations: 1     Fields:    Translation:HumansCells
    2. Costanzo G, Cordeddu W, Chessa L, Del Giacco S, Firinu D. COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic. World J Clin Cases. 2021 Jul 16; 9(20):5352-5357. PMID: 34307589.
      Citations:    
    3. Carta MG, Minerba L, Demontis R, Orrù G, Romano F, Scano A, Restivo A, Del Giacco S, Deidda S, Firinu D, Campagna M, Meloni F, Cossu G, Sancassiani F, Chessa L, Kalcev G, Littera R, Zorcolo L, Aviles-Gonzale CI, Usai P. The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature. J Public Health Res. 2021 Jun 07; 10(4). PMID: 34121380.
      Citations:    
    4. Cappellacci F, Anedda G, Del Giacco S, Coghe F, Cappai R, Canu GL, Erdas E, Calò PG, Medas F, Firinu D. Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study. Ann Med Surg (Lond). 2021 Jun; 66:102375. PMID: 33968401.
      Citations:    
    5. Milito C, Lougaris V, Giardino G, Punziano A, Vultaggio A, Carrabba M, Cinetto F, Scarpa R, Delle Piane RM, Baselli L, Ricci S, Rivalta B, Conti F, Marasco C, Marzollo A, Firinu D, Pulvirenti F, Lagnese G, Vivarelli E, Cancrini C, Martire B, Danieli MG, Pession A, Vacca A, Azzari C, Fabio G, Matucci A, Soresina AR, Agostini C, Spadaro G, Badolato R, Cicalese MP, Aiuti A, Plebani A, Pignata C, Quinti I. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021 Jul; 9(7):2904-2906.e2. PMID: 33894392.
      Citations: 5     Fields:    Translation:Humans
    6. Littera R, Campagna M, Deidda S, Angioni G, Cipri S, Melis M, Firinu D, Santus S, Lai A, Porcella R, Lai S, Rassu S, Scioscia R, Meloni F, Schirru D, Cordeddu W, Kowalik MA, Serra M, Ragatzu P, Carta MG, Del Giacco S, Restivo A, Deidda S, Orrù S, Palimodde A, Perra R, Orrù G, Conti M, Balestrieri C, Serra G, Onali S, Marongiu F, Perra A, Chessa L. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience. Front Immunol. 2020; 11:605688. PMID: 33343579.
      Citations: 22     Fields:    Translation:Humans
    7. Deidda S, Tora L, Firinu D, Del Giacco S, Campagna M, Meloni F, Orrù G, Chessa L, Carta MG, Melis A, Spolverato G, Littera R, Perra A, Onali S, Zorcolo L, Restivo A. Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management. Expert Rev Gastroenterol Hepatol. 2021 Jan; 15(1):41-50. PMID: 32955375.
      Citations: 8     Fields:    Translation:HumansCells
    8. Medas F, Cappellacci F, Anedda G, Canu GL, Del Giacco S, Calò PG, Firinu D. Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery. Ann Med Surg (Lond). 2020 Dec; 60:261-262. PMID: 33163178.
      Citations: 1     
    9. Vultaggio A, Agache I, Akdis CA, Akdis M, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774. PMID: 32500526.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    10. Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz AR, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe KF, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner AH, Horak F, Wöhrl S, et al. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. 2020; 4:53-68. PMID: 32915172.
      Citations: 8